# Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy

> **NCT04295330** · NA · COMPLETED · sponsor: **West China Hospital** · enrollment: 260 (actual)

## Conditions studied

- Primary Liver Cancer

## Interventions

- **DRUG:** Lidocaine Hydrochloride, Injectable
- **DRUG:** 0.9% normal saline

## Key facts

- **NCT ID:** NCT04295330
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-27
- **Primary completion:** 2022-05-27
- **Final completion:** 2022-05-27
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295330, "Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04295330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*